Bulletin Board
Archived Bulletin Board
About John
Latest Ideas
Symptoms
Tests and Drugs
Weight Loss Experiment
Hyperthyroidism
Hypothyroidism
Supplement List
Medical Science
Heredity
Other Diseases
Thyroid Physiology
Deeper Studies
Nutrients and Toxics
Hair Analysis
Book Reports
Glossary
Table of Contents | |
MITRAL VALVE PROLAPSE (MVP)
My feeling is that MVP is a condition caused by copper
deficiency. Copper is essential for the formation of collagen which forms
the structure of all the body. When copper gets deficient, MVP, Graves',
hernias, gray hair, etc. result.
- In the following study it is stated that " In contrast to
early reports, true "MVP syndrome" as revealed by controlled
studies consists of low body weight and blood pressure, minor skeletal
abnormalities, orthostatic hypotension, palpitations, and mitral
regurgitation that is usually mild." The symptoms of low body
weight and palpitations sounds like the symptoms of copper (and iron)
deficiency.
Curr Opin Cardiol 1995 Mar;10(2):107-16 |
|
Recent developments in the diagnosis and management of
mitral valve prolapse.
Devereux RB
Division of Cardiology, New York Hospital-Cornell Medical Center, NY 10021,
USA.
Mitral valve prolapse (MVP), which occurs in about 3% of adults, is usually
a primary, dominantly inherited condition. MVP may be diagnosed by
auscultation of a mid-systolic click and late-systolic murmur that move
dynamically with postural maneuvers. M-mode echocardiography confirms MVP by
demonstrating late-systolic prolapse and two-dimensional echocardiography
reveals leaflet billowing into the left atrium. Echocardiography identifies
severe forms of MVP by documenting significant mitral regurgitation,
enlargement and thickening of the mitral leaflets and annulus, and loss of
leaflet apposition. In contrast to early reports, true "MVP
syndrome" as revealed by controlled studies consists of low body weight
and blood pressure, minor skeletal abnormalities, orthostatic hypotension,
palpitations, and mitral regurgitation that is usually mild. Complications
of MVP include progressive mitral regurgitation, infective endocarditis,
orthostatic syncope, and possible risks of neurologic ischemia and
arrhythmic sudden death. Risk factors we have identified for complications
among patients with MVP include older age, male gender, the presence of
mitral regurgitation, and possibly, higher weight and blood pressure. The
cumulative risk of all complications of MVP by age 75 is from 5% to 10% for
affected men and 2% to 5% for affected women. Patients with MVP who have
neither a murmur nor Doppler evidence of mitral regurgitation may be
reassured that their condition is benign. For other patients with MVP we
have shown that oral antibiotic prophylaxis is cost-effective. The presence
and severity of mitral regurgitation govern the frequency and intensiveness
of follow-up.
- One of the dangers for people with MVP is bacterial endocarditis which
is a bacteria infection of the heart. Bacteria which can cause this
condition may enter the body through surface skin cuts or during dental or
other operations. For this reason, antibiotics are prescribed before
dental procedures. In the following article it is stated that
"most cases of endocarditis are not attributable to an invasive
procedure" but antibiotic pre-treatment is recommended for certain
patients with MVP.
J Am Dent Assoc 1997 Aug;128(8):1142-51 |
|
Prevention of bacterial endocarditis: recommendations by
the American Heart Association.
Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz
MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW,
Levison ME, Peter G, Zuccaro G Jr
OBJECTIVE: To update recommendations issued by the American Heart
Association last published in 1990 for the prevention of bacterial
endocarditis in individuals at risk for this disease. PARTICIPANTS: An ad
hoc writing group appointed by the American Heart Association for their
expertise in endocarditis and treatment with liaison members representing
the American Dental Association, the infectious Diseases Society of America,
the American Academy of Pediatrics and the American Society for
Gastrointestinal Endoscopy. EVIDENCE: The recommendations in this article
reflect analyses of relevant literature regarding procedure-related
endocarditis, in vitro susceptibility data of pathogens causing endocarditis,
results of prophylactic studies in animal models of endocarditis and
retrospective analyses of human endocarditis cases in terms of antibiotic
prophylaxis usage patterns and apparent prophylaxis failures. MEDLINE
database searches from 1936 through 1996 were done using root words
endocarditis, bacteremia and antibiotic prophylaxis. Recommendations in this
document fall into evidence level III of the U.S. Preventive Services Task
Force categories of evidence. CONSENSUS PROCESS: The recommendations were
formulated by the writing group after specific therapeutic regimens were
discussed. The consensus statement was subsequently reviewed by outside
experts not affiliated with the writing group and by the Science Advisory
and Coordinating Committee of the American Heart Association. These
guidelines are meant to aid practitioners but are not intended as the
standard of care or as a substitute for clinical judgment. CONCLUSIONS:
Major changes in the updated recommendations include the following: (1)
emphasis that most cases of endocarditis are not attributable to an invasive
procedure; (2) cardiac conditions are stratified into high-, moderate-
and negligible-risk categories based on potential outcome if endocarditis
develops; (3) procedures that may cause bacteremia and for which prophylaxis
is recommended are more clearly specified; (4) an algorithm was developed to
more clearly define when prophylaxis is recommended for patients with mitral
valve prolapse; (5) for oral or dental procedures the initial amoxicillin
dose is reduced to 2 g, a follow-up antibiotic dose is no longer
recommended, erythromycin is no longer recommended for penicillin-allergic
individuals, but clindamycin and other alternatives are offered.
If you have any experiences with MVP or run across any info
which might help others, please forward it to me for posting here. Thanks. John
Here is an interesting exchange from
hyperthyroidism@egroups.com:
Subj: [hyperthyroidism] Re: Graves + Paxil + MVP
Date: 6/5/00 5:46:03 PM Pacific Daylight Time
From: tnccline@nemonet.com (Christine Cline)
Reply-to: hyperthyroidism@egroups.com
To: hyperthyroidism@egroups.com
--- In hyperthyroidism@egroups.com, KTenn36117@a... wrote:
Hello Deb,
It is interesting that I've noticed that a few people in the group
who have thyroid problems ended up having mitral valve prolapse with mitral
reguirgitation. I was diagnostic as have MVP w/MR in January and
February.
This was news to me. I really thought it might be inherited cuz
my
father had that and he had a mitral valve tear repaired about 3 years ago.
Now it appears that one by one have come forward telling us that they were just
recently having MVP along with Thyroid problems. I wondered if
this is a big connection between thyroid and MVP???? What do you think??? John???
Kozy
Response from Christine:
Hi All!
Personally, I have yet to find a Graves' patient who HASN'T been
diagnosed with Mitral Valve Prolapse, myself included.
The following is an excerpt from Dr. Walt Stoll, and it exposes the
Mitral Valve Prolapse smokescreen for what it is:
"Mitral Valve Prolapse--the Current FAD Diagnosis (a diagnosis of
convenience for the physician)
"The valvular condition described by this medical FAD is a harmless
"normal varient" of the structure of the heart. The physician uses it
as a blanket "explanation" for a myriad of symptoms the allopathic
paradigm has no way of explaining separately. The physician says:
"NOW we know what was causing all those symptoms you have had so long so we don't have to think about them anymore. Here take this pill for your
MVP and go live with it."
"The Mitral Valve Prolapse (MVP) diagnosis is a current fad in
medicine that has no clinical significance. Just because we CAN
diagnose something doesn't mean it is important to that person's
health. Unfortunately, putting a name to someone's symptoms does
nothing about identifying the causes for them. One could have their
MVP surgically corrected to normal and NONE of their symptoms,
ascribed to the MVP, would change at all. As a matter of fact, this
was actually done in the early days of this "diagnosis" and the fact
that it did not change symptoms at all powerfully pushed the
profession to their present stand that this is a normal varient of
anatomy and is truly a non-symptomatic condition.
"Unfortunately, by the time the profession realized this, many
physicians found how convenient it was to not have to face their
multiply symptomed patient and admit that they had no idea what was
causing their symptoms. Finally, they had some learned thing to tell
the patient and it felt so GOOD that it is now very hard for them to
let go of their "pacifier" and, once again, admit to the patient that
they have no idea what is causing all their symptoms. SO, until the
public becomes educated, they will continue taking medications for an
imaginary condition."
So relax - it ain't so bad after all!!
Chris |